What these answers show

Clearer evidence boundaries, with one persistent diagnostic miss.

MontMedical Pro scores higher on 9 cases, OpenEvidence on 1, with 1 tie. The means are 9.36/10 and 7.91/10 respectively. These figures describe this selection and rubric.

MontMedical’s strongest distinctions

In the Castleman case, the fresh answer recognises the syndrome without inventing nodal architecture, polyclonality or an IgG4 ratio. In the histiocytic sarcoma case, it separates tumour identity from ancestry and addresses both admixed and engulfed lymphoma DNA. In VEXAS, it preserves the leading diagnosis while distinguishing a same-cell configuration from the order of clonal events.

The haemophilia answer distinguishes emicizumab’s assay effects from inhibitor eradication. The interferon-gamma answer separates transferred IgG-mediated functional inhibition from direct proof of the proposed antigen target. These are specific differences in experimental interpretation.

Where OpenEvidence is stronger

NCF4/p40phox deficiency remains MontMedical’s clear weakness. The fresh answer describes the missing ingestion-associated oxidant measurement and rejects automatic classic-CGD prognosis, but never names the most persuasive specific disorder. Its generic B-cell CGD study is less relevant than the published p40phox cohort. OpenEvidence identifies NCF4 and connects the cell- and stimulus-dependent pattern, although some of its mechanistic wording is too absolute. The fresh MontMedical result is retained at 7.0/10, against OpenEvidence’s 9.0/10.

What still needs improvement

MontMedical should keep a supported specific diagnosis prominent: delayed haemothorax, pituitary apoplexy and probable anti-PIT-1 hypophysitis could be ranked more directly in the respective openings. OpenEvidence’s larger deductions concern invented observations, premature causal or clonal conclusions and overgeneralised diagnostic rules. Both full answer sets remain visible for inspection.

The refresh supports a difference in these retained diagnostic explanations. Independent blinded evaluation on new cases is needed to establish clinical diagnostic performance.